参考文献/References:
[1] ROMAGRODRIGUESC,MENDESR,BAPTISTAPV,etal.Targetingtumormicroenvironmentforcancertherapy[J].Internationaljournalof molecularsciGences,2019,20(04):840.[2] RUSSELLL,PENGK W.TheemergingroleofoncoGlyticvirustherapyagainstcancer[J].Chineseclinicaloncology,2018,7(02):16.[3] LUNDSTROM K.LatesttrendsincancertherapyapGplyingviralvectors[J].Future Virology,2017,12(11):667G684.[4] NORDNESSO,BRENNECKEJF.Iondissociationinionicliquidsandionicliquidsolutions[J].ChemicalReGviews,2020,120(23):12873G12902.[5] BENEDETTO A,BALLONEP.RoomGtemperatureiGonicliquidsandbiomembranes:settingthestageforapplicationsinpharmacology,biomedicine,andbioGnanotechnology[J].Langmuir,2018,34(33):9579G9597.[6] JAVEDF,ULLAHF,ZAKARIA M R,etal.AnapGproach to classification and hiGtech applications ofroomGtemperatureionicliquids(RTILs):Areview[J].JournalofMolecularLiquids,2018,271:403G420.[7] DIAS A R,COSTA ‐ RODRIGUES J,FERGNANDES M H,etal.Theanticancerpotentialofionicliquids[J].ChemMedChem,2017,12(01):11G18.[8] DIASA R,COSTAGRODRIGUESJ,TEIXEIRA C,etal.Ionicliquidsfortopicaldeliveryincancer[J].Current medicinalchemistry,2019,26(41):7520G7532.[9] ALBADAWIH,ZHANGZ,ALTUNI,etal.PercuGtaneousliquidablationagentfortumortreatmentanddrugdelivery[J].Sciencetranslationalmedicine,2021,13(580):eabe3889.[10]ZAKREWSKY M,BANERJEE A,APTE S,etal.Cholineandgeranatedeepeutecticsolventasabroad‐spectrumantisepticagentforpreventiveandtheraGpeuticapplications[J].Advancedhealthcarematerials,2016,5(11):1282G1289.[11]CHENGYQ,WANGSB,LIUJH,etal.Modifyingthetumour microenvironmentandrevertingtumourcells:Newstrategiesfortreating malignanttumours[J].CellProliferation,2020,53(08):e12865.[12]LIUBL,ROBINSON M,HANZQ,etal.ICP34.5deletedherpessimplexviruswithenhancedoncolytic,immunestimulating,andantiGtumourproperties[J].Genetherapy,2003,10(04):292G303.[13]MAHASA KJ,ELADDADIA,DEPILLISL,etal.OncolyticpotencyandreducedvirustumorGspecificityinoncolyticvirotherapy.A mathematicalmodellingapGproach[J].Plosone,2017,12(09):e0184347.[14]V?H?GKOSKELA M,HINKKANEN A.TumorreGstrictionstooncolyticvirus[J].Biomedicines,2014,2(02):163G194.[15]BAIY,HUIP,DUX,etal.Updatestotheantitumormechanism ofoncolyticvirus[J].Thoracic Cancer,2019,10(05):1031G1035.[16]MAJ,RAMACHANDRAN M,JINC,etal.CharacGterizationofvirusGmediatedimmunogeniccancercelldeathandtheconsequencesforoncolyticvirusGbasedimmunotherapyofcancer[J].Celldeath & disease,2020,11(01):1G15.[17]TeimooriA,SoleimanjahiH,PourasgariF.CompariGsonofrotavirus RF strainand HSVG1titration byCCID50% and plaqueassays[J].Pathobiology ReGsearch,2012,15(02):35G45.[18]LIH,ZHOU L,ZHOUJ,etal.UnderlyingmechaGnismsanddruginterventionstrategiesforthetumourmicroenvironment[J].Journal of Experimental &ClinicalCancerResearch,2021,40(01):1G21.[19]?ZT?RKGATAR K,ERO^GLU H,?ALI?S.Noveladvancesintargeteddrugdelivery[J].Journalofdrugtargeting,2018,26(08):633G642.[20]ELIAI,HAIGISMC.MetabolitesandthetumourmiGcroenvironment:fromcellularmechanismstosystemicmetabolism[J].Nature Metabolism,2021,3(01):21G32.[21]AYOBAZ,RAMASAMY TS.Cancerstemcellsaskeydriversoftumourprogression[J].JournalofbioGmedicalscience,2018,25(01):1G18.[22]PEARLT M,MARKERTJM,CASSADY K A,etal.OncolyticvirusGbasedcytokineexpressiontoimGproveimmuneactivityinbrainandsolidtumors[J].MolecularTherapyGOncolytics,2019,13:14G21.